Skip to search formSkip to main contentSkip to account menu

Brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan]

Known as: brimonidine tartrate 1.5 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [ALPHAGAN P], Alphagan P 0.15 % Ophthalmic Drops, Alphagan 1.5 MG/ML Ophthalmic Solution 
National Institutes of Health

Related topics

Related topics

14 relations
AlphaganBrimonidine tartrateCalcium ChlorideCarboxymethylcellulose Sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE ( 58 ) Field of Classification Search None
, 15 ( 1 ) . Data Sheet for Brimonidine , 2007 , 1 Page . Data Sheet for Timolol , 2007 , 1 Page . David , Robert et al… 
2017
2017
8 Neural Mechanisms Underlying Brimonidine ’ s Protection of Retinal Ganglion Cells in Experimental Glaucoma
Glaucoma is a neurodegenerative disease characterized by a progressive loss of retinal ganglion cells (RGCs), the output neurons… 
2014
2014
Структурно-функциональные и биомеханические показатели пациентов с первичной открытоугольной глаукомой при адъювантной терапии 0,15% бримонидином
PURPOSE: To evaluate the necessity of including the selective alpha-adrenergic agonist brimonidine in the complex drug treatment… 
2011
2011
Neural Mechanisms Underlying Brimonidine’s Protection of Retinal Ganglion Cells in Experimental Glaucoma
Glaucoma is a neurodegenerative disease characterized by a progressive loss of retinal ganglion cells (RGCs), the output neurons… 
Review
2004
Review
2004
Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan®) in children
AbstractIntroduction Brimonidine 0.2% (Alphagan®) is a topical alpha-2 agonist widely used as an antihypertensive. There have… 
2003
2003
Evaluation of the comfort of Alphagan® P compared with Alphagan® in irritated eyes
The tolerability of brimonidine tartrate 0.15%—referred to as bromonidine-Purite® 0.15% in this study—was compared with… 
2002
2002
A Comparison of Efficacy, Tolerability, and Patient-Reported Measures Between Cosopt® and the Concomitant Administration of Alphagan® and Timolol
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)